Ultragenyx Pharmaceutical Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2020
Total Assets: $1.76B
Liabilities Breakdown FY2020
Total Liabilities: $605.2M
Asset Breakdown
Total Assets: $1.76B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $713.5M | 40.6% |
| Accounts Receivable | $23.1M | 1.3% |
| Inventory | $13.0M | 0.7% |
| Property, Plant & Equipment | $73.5M | 4.2% |
| Goodwill | $44.4M | 2.5% |
| Intangible Assets | $131.1M | 7.5% |
| Other Assets | $760.9M | 43.2% |
Liabilities Breakdown
Total Liabilities: $605.2M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $12.9M | 2.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $592.3M | 97.9% |